Breast Cancer Demographics, Types and Management Pathways: Can Western Algorithms be Optimally used in Eastern Countries?

被引：9

作者：

Chakraborty, S. ^{[1
]}

Wadasadawala, T. ^{[2
]}

Ahmed, R. ^{[3
]}

Coles, C. ^{[4
]}

Chatterjee, S. ^{[1
]}

机构：

[1] Tata Med Ctr, Dept Radiat Oncol, Kolkata, India

[2] Tata Mem Hosp, Dept Radiat Oncol, Mumbai, Maharashtra, India

[3] Tata Med Ctr, Dept Surg Oncol, Kolkata, India

[4] Addenbrookes Hosp, Dept Clin Oncol, Cambridge, England

来源：

CLINICAL ONCOLOGY | 2019年 / 31卷 / 08期

关键词：

Breast cancer; breast surgery; hypofractionation; immunohistochemistry; India; UK; PATHOLOGICAL COMPLETE RESPONSE; RADIATION-THERAPY; AMERICAN SOCIETY; CONTROLLED-TRIAL; NODE BIOPSY; INDIA; SENTINEL; WOMEN; RECOMMENDATIONS; PROGESTERONE;

D O I：

10.1016/j.clon.2019.05.024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Over the past decade, breast cancer has overtaken cervical cancer to become the most common cancer among women in India, as in most Western nations. In addition to the high incidence, the morbidity and mortality associated with this malignancy are disproportionately higher in India. Although some efforts are being made to increase awareness about this disease, a large majority of Indian patients present with advanced disease. Here, important institutional data and treatment outcomes are reviewed and compared with data from the West. Additionally, we highlight recent efforts in setting up collaborative multicentre trials in breast cancer in India and suggest some ways forward to improve outcomes. (C) 2019 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.

引用

页码：502 / 509

页数：8

共 68 条

[1] Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer – a Single Centre Study. (PPLB – 01) [J].

Agrawal S. ;

Banswal L. ;

Saha A. ;

Arun I. ;

Datta S.S. ;

Chatterjee S. ;

Ahmed R. .

Indian Journal of Surgical Oncology, 2016, 7 (4) :397-406

[2] Triple negative breast cancer: an Indian perspective [J].

Akhtar, Murtaza ;

Dasgupta, Subhrajit ;

Rangwala, Murtuza .

BREAST CANCER-TARGETS AND THERAPY, 2015, 7 :239-243

[3] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials [J].

Alberro, J. A. ;

Ballester, B. ;

Deulofeu, P. ;

Fabregas, R. ;

Fraile, M. ;

Gubern, J. M. ;

Janer, J. ;

Moral, A. ;

de Pablo, J. L. ;

Penalva, G. ;

Puig, P. ;

Ramos, M. ;

Rojo, R. ;

Santesteban, P. ;

Serra, C. ;

Sola, M. ;

Solarnau, L. ;

Solsona, J. ;

Veloso, E. ;

Vidal, S. ;

Abe, O. ;

Abe, R. ;

Enomoto, K. ;

Kikuchi, K. ;

Koyama, H. ;

Masuda, H. ;

Nomura, Y. ;

Ohashi, Y. ;

Sakai, K. ;

Sugimachi, K. ;

Toi, M. ;

Tominaga, T. ;

Uchino, J. ;

Yoshida, M. ;

Coles, C. E. ;

Haybittle, J. L. ;

Moebus, V. ;

Leonard, C. F. ;

Calais, G. ;

Garaud, P. ;

Collett, V. ;

Davies, C. ;

Delmestri, A. ;

Sayer, J. ;

Harvey, V. J. ;

Holdaway, I. M. ;

Kay, R. G. ;

Mason, B. H. ;

Forbe, J. F. ;

Franci, P. A. .

LANCET ONCOLOGY, 2018, 19 (01) :27-39

[4]

Ambroise M, 2011, ASIAN PAC J CANCER P, V12, P625

[5]

[Anonymous], NAT CANC GRID GUID B

[6]

[Anonymous], J CANC RES THER SS4

[7]

[Anonymous], 80 UN IS COUNTR HLTH

[8]

[Anonymous], REC PERT ADJ TREATM

[9]

[Anonymous], BREAST CANC UPD

[10]

[Anonymous], 26 WORLD CANC ONC C

← 1 2 3 4 5 6 7 →